[1]
Kumar, V. and Singh, A. 2021. Targeting N17 domain as a potential therapeutic target for the treatment of Huntington disease: An opinion. EXCLI Journal. 20, (Jun. 2021), 1086–1090. DOI:https://doi.org/10.17179/excli2021-3670.